Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: The SardiNIA Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 8, 2009, Pages 532-541

  Scuteri, A ^a   Najjar, S S ^c   Orru', M ^b   Albai, G ^b   Strait, J ^c   Tarasov, K V ^c   Piras, M G ^b   Cao, A ^b   Schlessinger, D ^c   Uda, M ^b   Lakatta, E G ^c  

^a INRCA   (Italy)

^b CNR   (Italy)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Control; Diabetes; Hypercholesterolemia; Hypertension; Population; Subclinical vascular disease; Treatment

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; ATTITUDE TO HEALTH; AWARENESS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIABETES MELLITUS; DRUG UTILIZATION; DYSLIPIDEMIA; FEMALE; FOUNDER EFFECT; HUMAN; HYPERTENSION; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; AWARENESS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DRUG UTILIZATION; DYSLIPIDEMIAS; FEMALE; FOUNDER EFFECT; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; HYPOGLYCEMIC AGENTS; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 67651093563     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.11.004     Document Type: Article

References (52)

1. Muntner P., Garrett E., Klag M.J., and Coresh J. Trends in stroke prevalence between 1973 and 1991 in the US population 25 to 74 years of age. Stroke 33 (2002) 1209-1213
2. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104 (2001) 2855-2864
3. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., Fortmann S., Sans S., Tolonen H., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 355 (2000) 675-687
4. Ford E.S., Mokdad A.H., Giles W.H., and Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003) 2185-2189
5. Wolf-Maier K., Cooper R.S., Kramer H., Banegas J.R., Giampaoli S., Joffres M.R., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43 (2004) 10-17
6. Wang Y.R., Alexander G.C., and Stafford R.S. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med 167 (2007) 141-147
7. Najjar S.S., Scuteri A., and Lakatta E.G. Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 46 (2005) 454-462
8. Pilia G., Chen W.M., Scuteri A., Orru M., Albai G., Dei M., et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2 (2006) e132
9. Scuteri A., Sanna S., Chen W., Uda M., Albai G., Strait J., et al. Genome wide association scan shows genetic variants in the FTO gene are associated with obesity related traits. PLoS Genet 3 7 (2007) e115
10. Scuteri A., Chen C.H., Yin F.C., Chih-Tai T., Spurgeon H.A., and Lakatta E.G. Functional correlates of central arterial geometric phenotypes. Hypertension 38 (2001) 1471-1475
11. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25 (2007) 1105-1187
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
13. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Available from http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf.
14. Scuteri A., Najjar S.S., Muller D.C., Andres R., Hougaku H., Metter E.J., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
15. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
16. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340 (1999) 14-22
17. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., and Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96 (1997) 1432-1437
18. Scuteri A., Tesauro M., Appolloni S., Preziosi F., Brancati A.M., and Volpe M. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 25 (2007) 1035-1040
19. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prevent Rehabil 10 Suppl 1 (2003) S1-S78
20. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
21. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 106 (2002) 388-391
22. Staessen J.A., Wang J.G., and Thijs L. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1st March 2003. J Hypertens 21 (2003) 1055-1076
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 25 suppl 1 (2002) S1-147
24. Smith Jr. S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 104 (2001) 1577-1579
25. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., and Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49 (2007) 69-75
26. Antikainen R.L., Moltchanov V.A., Chukwuma C., Kuulasmaa K.A., Marques-Vidal P.M., Sans S., et al. WHO MONICA Project. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 13 (2006) 13-29
27. Brindel P., Hanon O., Dartigues J.F., Ritchie K., Lacombe J.M., Ducimetiere P., et al. 3C Study Investigators. Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens 24 (2006) 51-58
28. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-524
29. Barzilay J.I., Spiekerman C.F., Kuller L.H., Burke G.L., Bittner V., Gottdiener J.S., et al. Cardiovascular Health Study. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24 (2001) 1233-1239
30. Saydah S.H., Loria C.M., Eberhardt M.S., and Brancati F.L. Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24 (2001) 447-453
31. Muhlestein J.B., Anderson J.L., Horne B.D., Lavasani F., Allen Maycock C.A., Bair T.L., et al. Intermountain Heart Collaborative Study Group. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146 (2003) 351-358
32. Taubert G., Winkelmann B.R., Schleiffer T., März W., Winkler R., Gök R., et al. Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145 (2003) 285-291
33. Tenenbaum A., Motro M., Fisman E.Z., Boyko V., Mandelzweig L., Reicher-Reiss H., et al. Clinical impact of borderline and undiagnosed diabetes mellitus in patients with coronary artery disease. Am J Cardiol 86 (2000) 1363-1366 A4-A5
34. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendíc S., Rydén L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
35. Henry R.M., Kostense P.J., Spijkerman A.M., Dekker J.M., Nijpels G., Heine R.J., et al. Hoorn Study. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107 (2003) 2089-2095
36. Scuteri A., Tesauro M., Rizza S., Iantorno M., Federici M., Lauro D., et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 18 (2008) 349-356
37. Sharma A.M., Wittchen H.U., Kirch W., Pittrow D., Ritz E., Göke B., et al. HYDRA Study Group. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 22 (2004) 479-486
38. Mancia G., Volpe R., Boros S., Ilardi M., and Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens 22 (2004) 51-57
39. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
40. Koro C.E., Bowlin S.J., Bourgeois N., and Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27 (2004) 17-20
41. Goff Jr. D.C., Bertoni A.G., Kramer H., Bonds D., Blumenthal R.S., Tsai M.Y., et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 113 (2006) 647-656
42. O'Meara J.G., Kardia S.L., Armon J.J., Brown C.A., Boerwinkle E., and Turner S.T. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 164 (2004) 1313-1318
43. Lloyd-Jones D.M., Evans J.C., Larson M.G., O'Donnell C.J., Roccella E.J., and Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 36 (2000) 594-599
44. Hyman D.J., and Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345 (2001) 479-486
45. Ford E.S., and DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes: findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol 133 (1991) 1220-1230
46. Gu K., Cowie C.C., and Harris M.I. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21 (1998) 1138-1145
47. Panzram G. Mortality and survival in type 2 diabetes mellitus. Diabetologia 30 (1987) 123-131
48. Bertoni A.G., Krop J.S., Anderson G.F., and Brancati F.L. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 25 (2002) 471-475
49. Saydah S.H., Eberhardt M.S., Loria C.M., and Brancati F.L. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 156 (2002) 714-719
50. Fagard R.H., Van Den Enden M., Leeman M., and Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 20 (2002) 1297-1302
51. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 357 (2001) 995-1001
52. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40 (2008) 161-169 doi: 10.1038/ng.76